Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature
Authors:
- Andrew KirbyAKAndrew Kirby
- Ibrahim HassanIHIbrahim Hassan
- James BurnieJBJames Burnie
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 52 (6) , 405-414
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- VoriconazoleClinical Therapeutics, 2003
- In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End PointsAntimicrobial Agents and Chemotherapy, 2003
- Aspergillus Discitis With Acute Disc AbscessSpine, 1994
- Carpal Aspergillus osteomyelitis: Case report and review of the literatureThe Journal of Hand Surgery, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Aspergillus DiscitisClinical Orthopaedics and Related Research, 1988
- Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combinationJournal of Antimicrobial Chemotherapy, 1978
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978
- Use of 5-Fluorocytosine in Patients with Impaired Renal FunctionBMJ, 1973